SPIA
CRBP icon

Steward Partners Investment Advisory’s Corbus Pharmaceuticals CRBP Stock Holding History

Steward Partners Investment Advisory’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10
Closed -$2K – 1877
2017
Q3 		$2K Hold
10
– – ﹤0.01% 1475
2017
Q2 		$1K Hold
10
– – ﹤0.01% 1502
2017
Q1 		$2K Buy
+10
New +$2.45K ﹤0.01% 1293

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Steward Partners Investment Advisory's CRBP Position: Q4 2017 in Review

Steward Partners Investment Advisory sold out of Corbus Pharmaceuticals (CRBP) in Q4 2017, closing a stake of 10 shares — an estimated $2K sold.

Steward Partners Investment Advisory first reported a position in CRBP in Q1 2017 and held it in 3 quarters. The position peaked at $2K in Q3 2017. 88 funds tracked by Wall St. Rank hold CRBP as of Q4 2017.

  • Steward Partners Investment Advisory reported no remaining Corbus Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 10 Corbus Pharmaceuticals shares in Q4 2017, an estimated $2K.
  • Steward Partners Investment Advisory first reported a position in Corbus Pharmaceuticals in Q1 2017 and held it in 3 quarters.
  • Steward Partners Investment Advisory's Corbus Pharmaceuticals position peaked at $2K in Q3 2017.
  • 88 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2017.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2017, filed 19 Jan 2018.